CNS Pharmaceuticals, Inc. (CNSP)
Largest Insider Buys in Sector
CNSP Stock Price History Chart
CNSP Stock Performance
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD …
Insider Activity of CNS Pharmaceuticals, Inc.
Over the last 12 months, insiders at CNS Pharmaceuticals, Inc. have bought $89,999 and sold $0 worth of CNS Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at CNS Pharmaceuticals, Inc. have bought $114,645 and sold $66,557 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Climaco John M (Chief Executive Officer) — $50,000. Downs Christopher (Chief Financial Officer) — $40,000. Evans Carl Anthony (director) — $10,000.
The last purchase of 166,666 shares for transaction amount of $50,000 was made by Climaco John M (Chief Executive Officer) on 2024‑02‑01.
List of Insider Buy and Sell Transactions, CNS Pharmaceuticals, Inc.
| 2024-02-01 | Chief Executive Officer | 166,666 3.2195% | $0.30 | $50,000 | -79.37% | |||
| 2024-02-01 | Chief Financial Officer | 66,666 1.2878% | $0.30 | $20,000 | -79.37% | |||
| 2024-02-01 | director | 33,333 0.6439% | $0.30 | $10,000 | -79.37% | |||
| 2024-02-01 | director | 33,333 0.6439% | $0.30 | $10,000 | -79.37% | |||
| 2023-08-22 | Chief Financial Officer | 27,000 0.4674% | $1.27 | $34,177 | -78.05% | |||
| 2023-08-16 | Chief Executive Officer | 2,750 0.0656% | $1.80 | $4,945 | -76.65% | |||
| 2023-04-19 | director | 2,500 0.1259% | $1.70 | $4,250 | -10.45% | |||
| 2023-04-17 | Chief Financial Officer | 3,100 0.1892% | $3.20 | $9,920 | -42.00% | |||
| 2023-04-12 | Chief Executive Officer | 15,000 0.8017% | $0.69 | $10,409 | +137.15% | |||
| 2023-04-10 | director | 7,173 0.3716% | $0.74 | $5,308 | +115.56% | |||
| 2023-03-28 | Sale | 10 percent owner | 10,000 0.551% | $1.04 | $10,400 | +63.13% | ||
| 2023-03-27 | Sale | 10 percent owner | 5,000 0.2623% | $1.09 | $5,450 | +48.17% | ||
| 2023-03-24 | Sale | 10 percent owner | 5,000 0.2485% | $1.08 | $5,400 | +42.11% | ||
| 2023-03-23 | Sale | 10 percent owner | 10,000 0.5395% | $1.08 | $10,800 | +54.29% | ||
| 2023-03-22 | Sale | 10 percent owner | 5,000 0.2552% | $1.08 | $5,400 | +45.50% | ||
| 2023-03-21 | Sale | 10 percent owner | 5,000 0.2623% | $1.10 | $5,500 | +46.82% | ||
| 2023-03-20 | Sale | 10 percent owner | 5,000 0.2599% | $1.08 | $5,400 | +48.17% | ||
| 2023-03-17 | Sale | 10 percent owner | 5,000 0.2646% | $1.13 | $5,650 | +44.64% | ||
| 2023-03-16 | Sale | 10 percent owner | 5,000 0.2756% | $1.24 | $6,200 | +37.29% | ||
| 2023-03-15 | Sale | 10 percent owner | 5,000 0.258% | $1.22 | $6,100 | +30.24% |
Insider Historical Profitability
| Climaco John M | Chief Executive Officer | 215676 0.3752% | $0.11 | 3 | 0 | +137.15% |
| Downs Christopher | Chief Financial Officer | 103438 0.1799% | $0.11 | 6 | 0 | <0.0001% |
| Gumulka Jerzy | director | 43006 0.0748% | $0.11 | 3 | 0 | +52.56% |
| Evans Carl Anthony | director | 33458 0.0582% | $0.11 | 1 | 0 |